# Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis

Study · id `cardio:ct-nct05217485` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05217485](<https://clinicaltrials.gov/study/NCT05217485>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05217485

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 125 participants.

## Technical summary

Registry record NCT05217485. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-03 (anticipated); primary completion 2023-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 125 participants (planned count; ClinicalTrials.gov record NCT05217485, source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)
- Planned start: 2022-03 (anticipated) (ClinicalTrials.gov record NCT05217485, source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)
- Primary completion: 2023-03 (anticipated) (ClinicalTrials.gov record NCT05217485, source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)
- Completion: 2024-03 (anticipated) (ClinicalTrials.gov record NCT05217485, source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05217485, source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05217485-2022-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
- Acronym: CAMS-AF
- Condition: Atrial Fibrillation
- Condition: Sepsis
- Condition: Infections
- Condition: Cardiac Arrhythmia
- Intervention (Device): Zio 14-day cardiac patch
- Lead sponsor: Cambridge University Hospitals NHS Foundation Trust
- Lead sponsor class: OTHER
- Collaborator: University of Cambridge
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Cambridge University Hospitals NHS Foundation Trust (`cardio:org-cambridge-university-hospitals-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: University of Cambridge (`cardio:org-university-of-cambridge`)

## Provenance

Content hash: 4623334d757a65d91585489a7e8405569114fd6856f8edd78f26f6ee360ffb89
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
